These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9827363)

  • 1. Increased serum concentrations of secretory leukoprotease inhibitor in patients with primary Sjögren's syndrome.
    Maruyama M; Sugiyama E; Hori T; Murayama R; Nakazaki S; Yamashita N; Kobayashi M
    In Vivo; 1998; 12(5):535-8. PubMed ID: 9827363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
    Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
    J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
    Grisius MM; Bermudez DK; Fox PC
    J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical study on secretory leukoprotease inhibitor (SLPI) in sera of patients with various pulmonary diseases].
    Sugimoto H; Hashimoto N; Ameshima S; Gejyo F; Ishizaki T; Miyabo S
    Rinsho Byori; 1995 Dec; 43(12):1267-72. PubMed ID: 8569039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
    Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
    Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome.
    Haga HJ; Rygh T
    J Rheumatol; 1999 Jun; 26(6):1291-5. PubMed ID: 10381045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
    Lin AL; Johnson DA; Stephan KT; Yeh CK
    J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum secretory leukoprotease inhibitor levels in chronic bronchitis and Sjögren's syndrome.
    Andoh Y; Shimura S; Saitoh H; Sasaki T; Mitsuhashi H; Shirato K
    Tohoku J Exp Med; 1997 Aug; 182(4):319-25. PubMed ID: 9352624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome.
    Hernández CC; Donadi EA; Reis ML
    J Rheumatol; 1998 Dec; 25(12):2381-4. PubMed ID: 9858433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjögren's syndrome.
    Pertovaara M; Jylhävä J; Uusitalo H; Pukander J; Helin H; Hurme M
    J Rheumatol; 2009 Nov; 36(11):2487-90. PubMed ID: 19833744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
    Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
    Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
    Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
    Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
    Janciauskiene S; Brandt L; Wallmark A; Westin U; Krakau T
    Exp Eye Res; 2006 Mar; 82(3):505-11. PubMed ID: 16202405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble CD44 in primary Sjögren's syndrome.
    Levesque MC; Mackin DA; Fleming JA; St Clair EW
    J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
    Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G
    Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum secretory leukoprotease inhibitor levels to diagnose pneumonia in the elderly.
    Kida K; Mizuuchi T; Takeyama K; Hiratsuka T; Jinno S; Hosoda K; Imaizumi A; Suzuki Y
    Am Rev Respir Dis; 1992 Dec; 146(6):1426-9. PubMed ID: 1360778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
    Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.